2026 Franchise 500
Unranked
—
units (2024)42.9%
year over yearUnits by Year
102021
Total outlets at year end, from FDD Item 20.
The Investment
Initial investment
$262,000 – $669,000
FDD Item 7
Franchise fee
$75,000
FDD Item 5
Ad fund
—
FDD Item 6
Financial performance
No
FDD Item 19 disclosure
Royalty
6.0% of Gross Sales
Leadership
Domenic Iacovone
President and CEO
Samantha Iacovone
CFO
Gina Iacovone
Chief Franchise Officer
Kameron Harris
President of Franchise Operations
On File
Franchisee records
5
Current roster rows
Signed, not open
2
FDD Item 20, Table 5
Franchising for
6 yrs
Franchise Disclosure Documents
Also in Hormone Replacement Therapy
More in Health & Wellness→Read from this brand's Franchise Disclosure Documents. FDD library maintained by AskTy; figures are as filed by the franchisor.